PATENT CLAIM ANALYSIS

Application Number: 16017251
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["424", "234100"]

Abstract:
The present invention relates to, in part, compositions comprising improved flagellin derived constructs and methods of using for vaccination, including adjuvants comprising flagellin-based agents.

Claim (Index 25):
A method of vaccinating a subject against a substance abuse disorder, comprising administering an effective amount of a vaccine comprising:\n (a) an adjuvant comprising:\n a flagellin-based agent comprising an amino acid sequence having at least 95% identity with SEQ ID NO: 2, and an aluminum gel or salt, \n wherein the ratio (w/w) of flagellin-based agent to aluminum gel or salt is about 1:500 or less and \n (b) an antigen, the antigen being a constituent of an infectious agent selected from a live and attenuated, killed, inactivated or toxoid, infectious agent.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 94.0
- Lexical Diversity: 1.12
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15500133', '12532225', '13898249', '15329870', '15446315']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6606888658557092
- 35 USC 102 Novelty (BERT): 0.6746056654648888
- Combined Prediction Score: 0.6620805458166272
- Mean Citation Score: 350.1240180000001
- Max Citation Score: 672.6575
- Similarity Product: 642.474302790761

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test